Millendo Therapeutics Inc (MLND)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -62.997 | -52.176 | -34.656 | -56.045 | -61.508 | -48.526 | -59.851 | -60.375 |
Return on Equity (%) | -69.988 | -59.096 | -39.575 | -67.023 | -77.793 | -81.045 | -131.699 | -131.424 |
Return on Invested Capital (%) | -70.7 | -59.953 | -39.465 | -68.586 | -77.386 | -63.864 | -87.554 | -96.169 |
Operating Margin (%) | -12566.462 | -17256.949 | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | -12597.243 | -17279.661 | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | 3.036 | 1.8 | 5.474 | 3.278 | 1.775 | 5.227 | 1.722 | 1.391 |
Earnings Per Share | -2.308 | -1.427 | -2.036 | -2.44 | -1.916 | -4.096 | -3.395 | -1.532 |
Cash Per Share | 1.233 | 0.44 | 5.486 | 3.42 | 2.009 | 7.501 | 2.969 | 2.038 |
Working Capital Per Share | 2.897 | 1.707 | 5.51 | 3.209 | 1.732 | 7.082 | 2.441 | 1.608 |
Operating Profit Per Share | -0.07 | -0.014 | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | -2.302 | -1.425 | -2.035 | -2.44 | -1.916 | -4.096 | -3.395 | -1.532 |
EBITDA Per Share | -2.302 | -1.425 | -2.035 | -2.44 | -1.916 | -4.096 | -3.395 | -1.532 |
Free Cash Flow Per Share | -2.298 | -1.469 | -2.033 | -2.423 | -1.923 | -4.13 | -3.402 | -1.543 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 35,64M | 35,73M | 13,36M | 18,27M | 19M | 6,91M | 10,52M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 10,52M | 11,59M | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 20,4M |
Ratio cours/bénéfice | -0,55 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 0,42 |
Ratio prix/valeur comptable | 0,61 |
Rendement de dividende | - |
Actions en circulation | 19,25M |
Volume moyen (1 semaine) | 0 |
Volume moyen (1 mois) | 0 |
Variation sur 52 semaines | - |
Plus haut sur 52 semaines | - |
Plus bas sur 52 semaines | - |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales